| Title |
A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma
|
|---|---|
| Published in |
Radiation Oncology, March 2018
|
| DOI | 10.1186/s13014-018-0992-3 |
| Pubmed ID | |
| Authors |
Rohann J. M. Correa, Belal Ahmad, Andrew Warner, Craig Johnson, Mary J. MacKenzie, Stephen E. Pautler, Glenn S. Bauman, George B. Rodrigues, Alexander V. Louie |
Mendeley readers
The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 53 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 6 | 11% |
| Student > Bachelor | 5 | 9% |
| Other | 4 | 8% |
| Lecturer | 3 | 6% |
| Researcher | 3 | 6% |
| Other | 10 | 19% |
| Unknown | 22 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 32% |
| Nursing and Health Professions | 6 | 11% |
| Psychology | 2 | 4% |
| Biochemistry, Genetics and Molecular Biology | 1 | 2% |
| Neuroscience | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 26 | 49% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2019.
All research outputs
#5,833,086
of 23,103,903 outputs
Outputs from Radiation Oncology
#238
of 2,079 outputs
Outputs of similar age
#102,304
of 332,477 outputs
Outputs of similar age from Radiation Oncology
#11
of 51 outputs
Altmetric has tracked 23,103,903 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 2,079 research outputs from this source. They receive a mean Attention Score of 2.7. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 332,477 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.